Who founded Kanvas Bio?

Kanvas Bio was founded by Matthew Cheng, Hao Shi, Iwijn De Vlaminck in 2020.

Who are Kanvas Bio's investors?

Kanvas Bio's investors include Bascom Ventures, Boutique Venture Partners, DCVC (Data Collective), FemHealth Ventures, Germin8 Ventures, Kicker Ventures, Pangaea Ventures Us Inc., Red Bear Ventures and 1 more.

How much funding has Kanvas Bio raised?

Kanvas Bio has disclosed $15.7M raised across 2 rounds.

Where is Kanvas Bio headquartered?

Kanvas Bio is headquartered in Monmouth Junction, US.

Kanvas Bio

Monmouth Junction, US · Founded 2020 · 42 employees on LinkedIn · 9 known investors

Find your way into Kanvas Bio

1,495 people in our graph share verified history with the Kanvas Bio team — schools, employers, funds. One of them is your warm intro.

Paul Kwanunlockedknows Iwijn De Vlaminck · together at Stanford University (overlapped)

×5knows the team · via Stanford University

×2knows the team · via Cornell

×2knows the team · via KU Leuven

×2knows the team · via Brigham and Women's Hospital

Kanvas Bio operates a platform for discovering, developing, and manufacturing live biotherapeutics based on the human gut microbiome. It combines high-resolution host-microbiome mapping with large-scale anaerobic co-culture manufacturing to support drug development for pharmaceutical and biotechnology partners.

Biotech Deep Tech Healthtech

Founders & leadership

Kanvas Bio was founded in 2020 by Matthew Cheng, Hao Shi, and Iwijn De Vlaminck.

Matthew Cheng inCo-FounderMatthew Cheng is an infectious disease specialist and medical microbiologist who leads Kanvas Bio, which develops live biotherapeutics based on the human gut microbiome.

Hao Shi inCo-founder · Chief Technology OfficerHao Shi is an executive officer and director at Kanvas Bio, which develops live biotherapeutics based on the human gut microbiome. He has expertise in sequencing and imaging technologies applied to biomedical research.

Iwijn De Vlaminck inCo-FounderIwijn De Vlaminck is a professor of Biomedical Engineering at Cornell University with a PhD in applied physics from IMEC Belgium and postdoctoral training in single-molecule biophysics and precision medicine at TU Delft and Stanford University. His research spans genomics, biophysics, and computational biology, with work on high-throughput diagnostics including cell-free DNA organ rejection tests, blood-based infection screening, and microbiome spatial mapping technologies.

Board

Jason Pontin in 𝕏Founding Board ChairGeneral Partner at DCVC (Data Collective)

Justin Smithline inBoard directorGeneral Partner at Triple Impact Capital

Investors · 9

Bascom VenturesBoston

Boutique Venture PartnersPalo Alto

DCVC (Data Collective)Palo Alto · $5M – $25M

FemHealth VenturesShort Hills

Germin8 VenturesChicago

Kicker VenturesMenlo Park · $100K – $1Mvia Masashi Kiyomine · inferred

Pangaea Ventures Us Inc.Vancouver · $500K – $1.5M

Red Bear VenturesIthaca · $200K – $1.3M

Triple Impact CapitalreportedSan Francisco · $250K – $600Kvia Justin Smithline · board

Reported raises · per SEC filings

Form D private placements

$15.7M disclosed across 2 rounds · 2023–2024

▶$3.9MraisedMar 2024 · 54 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Paul TheunissenDirector
Jason PontinDirector
Matthew ChengExecutive Officer, Director
Hao ShiExecutive Officer, Director

Offering amount: $10M
Amount sold: $3.9M
First sale: Mar 2024
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$11.8MraisedJun 2023 · 12 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Jason PontinDirector
Matthew ChengExecutive Officer, Director
Hao ShiExecutive Officer, Director
Iwijn De VlaminckExecutive Officer, Director
Justin SmithlineDirector

Offering amount: $12M
Amount sold: $11.8M
First sale: Jun 2023
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Kanvas Bio went on to found or lead other companies.

Jason PontinDirectorFounded Totus Medicines Iwijn De VlaminckExecutive Officer, DirectorFounded Romix Biosciences

In the news

Kanvas Biosciences, Inc. - BIO International Convention 2026convention.bio.org

Frequently asked questions

What does Kanvas Bio do?: Kanvas Bio operates a platform for discovering, developing, and manufacturing live biotherapeutics based on the human gut microbiome. It combines high-resolution host-microbiome mapping with large-scale anaerobic co-culture manufacturing to support drug development for pharmaceutical and biotechnology partners.
Who founded Kanvas Bio?: Kanvas Bio was founded by Matthew Cheng, Hao Shi, Iwijn De Vlaminck in 2020.
Who are Kanvas Bio's investors?: Kanvas Bio's investors include Bascom Ventures, Boutique Venture Partners, DCVC (Data Collective), FemHealth Ventures, Germin8 Ventures, Kicker Ventures, Pangaea Ventures Us Inc., Red Bear Ventures and 1 more.
How much funding has Kanvas Bio raised?: Kanvas Bio has disclosed $15.7M raised across 2 rounds.
Where is Kanvas Bio headquartered?: Kanvas Bio is headquartered in Monmouth Junction, US.